Abstract7
As the burden of Alzheimer’s dementia rises, so does our understanding of the cellular and molecular basis of this neurodegenerative disease. Some of the recent advances in the aetiopathogenesis of neurodegeneration include the finding that insulin receptor signalling is key to neurogenesis and synaptogenesis in the brain, especially in areas related to memory formation and storage, including the hippocampus. This suggests an association between impaired insulin receptor signalling and neurodegenerative events. To decipher this association, several animal models are being employed. Such models include transgenic and non-transgenic animals that range from invertebrates (Drosophila melanogaster and Caenorhabditis elegans), to vertebrates (mouse, rats and primates). The current review is an account of such models and how they have contributed to our understanding of the relationship between type 2 diabetes mellitus, ageing and dementia.
Similar content being viewed by others
References
Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135–163
Ahmad W (2013) Overlapped metabolic and therapeutic links between Alzheimer and diabetes. Mol Neurobiol 47:399–424
Akinola OB, Omotoso GO, Dosumu OO, Akinola OS, Olotufore F (2011) Diabetes-induced prefrontal Nissl substance deficit and the effects of neem-bitter leaf extract treatment. Int J Morphol 29:850–856
Akinola OB, Gabriel M, Suleiman A, Olorunsogbon (2012) Treatment of alloxan-induced diabetic rats with metformin or glitazones is associated with amelioration of hyperglycaemia and neuroprotection. The Open Diabetes J 5:8–12
Akinola O, Biliaminu S, Adediran R, Adeniye K, Abdulquadir F (2015) Characterization of prefrontal cortex microstructure and antioxidant status in a rat model of neurodegeneration induced by aluminium chloride and multiple low-dose streptozotocin. Metab Brain Dis 30:1531–1536
Alzheimer’s Disease International 2015. World Alzheimer’s report 2015
Barron AM, Rosario ER, Elteriefi R, Pike CJ (2013) Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer’s disease. PLoS One 8:e78554
Bondy SC (2016) Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer’s disease and age-related neurodegeneration. Neurotoxicology 52:222–229
Cao D, Lu H, Lewis TL, Li L (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 282:36275–36282
Carvalho C, Cardoso S, Correia SC, Santos RX, Santos MS, Baldeiras I, Oliveira CR, Moreira PI (2012) Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochiondrial abnormalities. Diabetes 61(5):1234–1242
Chen, Y., Tian, Z., Liang, Z., Sun, S., Dai, C.-I. & Lee, M. H. 2012. Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer’s disease. PLoS One, 7:e51432
Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity, vol 313. Science, pp. 1604–1610
Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E (2012) Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 1441:64–78
Defronzo, R. A., Simonson, D., Ferrannini, E. & Barret, E. 1981. Insulin resistance: a universal finding in diabetic states. Bull Schweiz Akad Med Wiss, 1981–1982:223–238.
Dostal V, Link CD (2010) Assaying beta amyloid toxicity using a transgenic C. elegans model. J Visualized Exper 44. doi:10.3791/2252.
Egefjord L, Geji M, Moller A, Brandgaard H, Al. E (2012) Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer’s disease - protocol for a controlled, randomized double-blind trial. Danish Med J 59:1–4
Elahi M, Hasan Z, Motoi Y, Matsumoto SE, Ishiguro K, Hattori N (2016) Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice. J Alzheimers Dis 25:25
Eldar-Finkelman H, Schreyer SA, Shinohara MM, Leboeuf RC, Krebs EG (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6 J mice. Diabetes 48:1–5
Fita IG, Enciu A, Stanoiu BP (2011) New insights on Alzheimer’s disease diagnostic. Romanian J Morphol Embryol 52:975–979
Hiltunen M, Khandelwal VK, Yaluri N, Tiilikainen T, Tusa M, Koivisto H, Krzisch M, Vepsalainen S, Makinen P, Kemppainen S, Miettinen P, Haapasalo A, Soininen H, Laakso M, Tanila H (2012) Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med 16:1206–1222
Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J 18:902–904
Hofman A, Ott A, Breteler MM (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349:151–154
Hoyer S (1997) Models of Alzheimer’s disease: cellular and molecular aspects. N Neural Transm 49:11–21
Hyun J, Hashimoto C (2011) Physiological effects of manipulating the level of insulin-degrading enzyme in insulin-producing cells of drosophila. Fly 5:53–57
International Diabetes Federation 2013. IDF diabetes atlas. 6th ed
Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer’s disease. PLoS One 4:0007917
Kim KW, Donato JJ, Berglund ED (2012) FOXO1 in the ventromedial hypothalamus regulates energy balance. J Clin Invest 122:2578–2589
Knight EM, Martins IVA, Gomosgoz S, Allan SM, Lawrence CB (2014) High-fat diet-induced memory impairment in triple-teansgenic Alzheimer’s disease (3xTgAD) mice is independent of chnages in amyloid and tau pathology. Neurobiol Aging 35:1821–1832
Kohjima M, Sun Y, Chan L (2010) Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer’s disease mouse model. Endocrinology 151:1532–1540
Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer’s model. CNS Neurol Disord Drug Targets 14:295–302
Leboucher, A., Laurent, C., Fernandez-Gomez, F. J., Burnouf, S., Troquier, L., Eddarkaoui, S., Demeyer, D., Caillierez, R., Zommer, N., Vallez, E., Bantubungi, K., Breton, C., Pigny, P., Buee-Scherrer, V., Staels, B., Hamdane, M., Tailleux, A., Buee, L. & Blum, D. 2013. Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes, 62, 1681–1688.
Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216–226
Li Z, Zhang W, Sima AF (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817–1824
Llorens-Martin, M., Jurado, J., Hernandez, F. & Avila, J. 2014. GSK-3beta, A pivotal kinase in Alzheimer disease. Front Mol Neurosci, 7:46
Madhavadas S, Kutty BM, Subramanian S (2014) Amyloid beta lowering and cognition enhancing effects of ghrelin receptor analog [D-Lys (3)] GHRP-6 in rat model of obesity. Indian J Biochem Biophys 51:257–262
Mehla J, Chauhan BC, Chauhan NB (2014) Experimental induction of type 2 diabetes mellitusin aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis 39:145–162
Meusel, L., Tchistiakova, E., Yuen, W., Machintosh, B. J., Anderson, N. D., & Greenwood, C. R. 2012. Cognitive decline and dmentia risk in type 2 diabetes. J Curr Clin Care 2(1): 6–16.
Morcos M, Hutter H (2009) The model Caenorhabditis elegans in diabetes mellitus and Alzheimer’s disease. J Alzheimers Dis 16:897–908
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) TRiple-transgenic model of Alzheimer’s disease with plaques and tangle, intracellular Abeta and synaptic dysfunction. Neuron 39:409–421
Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevaleve of obesity in the United States, 2009–2010. NCHS Data Brief 82:1–8
Onken B, Driscoll M (2010) Metformin induced a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1 and SKN-1. PLoS One 5(1):e8758
Parikh NM, Morgan R, Kunik ME (2012) Risk facotrs for dementia in pateints over 65 with diabetes. Int J Geriatr Psychiatry 26:749–757
Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-alpha regulates production of Alzheimer’s disease amyloid-beta peptides. Nature 423:435–439
Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S (2010) Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis 19:691–704
Qu, Z., Li, L., Sun, X., Zhao, Y., Zhang, J., Geng, Z., Fu, J. & Ren, Q. 2014. Glycogen synthase kinase 3 regulates production of amyloid beta peptide and tau phosphorylation in diabetic rat brain. Sci World J, 2014:878123.
Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes neurodegeneration and inflammation. Glycobiology 15(7):16R–28R
Ren H, Plum-Morschel L, Gutierrez-Juarez R, AL. E (2013) Blunted refeeding response and increased locomotor activity in mice lacking FoxO1 in synapsin-Cre-expressing neurons. Diabetes 62:3373–3383
Saharia, K., Arya, U., Kumar, R., Sahu, R., Das, C. K., Gupta, K., Dwivedi, H. & Subramaniam, J. R. 2012. Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Abeta proteotoxicity in Caenorhabditis elegans. Exp Gerontol, 47, 188–197.
Schubert M, Brazil D, Burks DJ (2003) Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084–7092
Schubert M, Gautam D, Surjo D, et al. (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 101:3100–3105
Sharma DR, Wani WY, Sunkaria A, Kandimalla RJ, Sharma RK, Verma D, Bal A, Gill KD (2016) Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience 324:163–176
Sohal, R. S., Weindruch, R. 1996. Oxidative stress, caloric restriction and aging. Science, 273(5271), 59–63.
Son JH, Shim JH, Kim KH, Ha JY, Han JY (2012) Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 44:89–98
Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M (2011) Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 108:3791–3796
Tilson HA, Peterson NJ (1987) Colchicine as an investigative tool in neurobiology. Toxicology 46:159–173
Tsuda M, Kobayashi T, Matsuo T, Aigaki T (2010) Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in drosophila. FEBS Lett 584:2916–2920
Umegaki H (2012) Neurodegeneration in diabetes mellitus. Adv Exp Med Biol 724:258–265
Van Dijk G, Van Heijningen S, Reijne AC, Nyakas C, Van Der Zee EA, Eisel ULM (2015) Integrative neurobiology of metabolic diseases, nueorinflammation, and neurodegeneration. Front Neurosci 9:1–19
Vandal M, White PJ, Tremblay C, St-Amour I, Chevrier G, Emond V, Lefrancois D, Virgili J, Planel E, Giguere Y, Marette A, Calon F (2014) Insulin reverses the high-fat diet-induced increase in brain Abeta and improves memory in an animal model of Alzheimer disease. Diabetes 63(12):4291–4301
Yaffe K, Lindquist K, Schwartz AV, Vitartas C, Vittinghoff E, Satterfied S, Simonsick EM, Launer L, Rosano C, Cauley JA, Harris T (2011) Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 77(14):1351–1356
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akinola, O.B. Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia. Metab Brain Dis 31, 1003–1010 (2016). https://doi.org/10.1007/s11011-016-9876-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-016-9876-0